{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:18:36Z","timestamp":1776194316631,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017891","name":"Landeszentrum Gesundheit Nordrhein-Westfalen","doi-asserted-by":"crossref","award":["LZG TG 72 004\/2016"],"award-info":[{"award-number":["LZG TG 72 004\/2016"]}],"id":[{"id":"10.13039\/100017891","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Women with <jats:italic>BRCA1\/2<\/jats:italic> mutations have a higher risk of developing breast and ovarian cancer compared to women of the general population. Various preventive options are available to deal with the increased risk of developing cancer. These include intensified breast cancer screening and risk-reducing bilateral mastectomy and salpingo-oophorectomy. The choice of a preventive option can lead to increased decisional conflict. To support these women in their decision-making process, two evidence-based decision aids were developed in an upstream research process and adapted to the German healthcare context. These will be evaluated within a randomised controlled trial (RCT) in terms of their effects on decision-making, women\u2019s level of information and psychological outcome variables.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A sample of 310 women carrying <jats:italic>BRCA1\/2<\/jats:italic> mutations (A) without a history of cancer or (B) with a history of unilateral breast cancer who have received post-test genetic counselling will be enrolled. Upon study consent, women will be randomly assigned to either the intervention or the control group. All participants will receive standard care including a physician\u2019s letter summarising the counselling content. After baseline data collection (t0), the intervention group receives the respective decision aid while the control group receives standard care only. The primary outcome variable assessed at a 3-month follow-up (t1) is the change of extent in decisional conflict (measured with the Decisional Conflict Scale). Secondary outcome variables comprise the stage of decision-making, self-reported symptoms of anxiety, depression and stress due to the genetic test result, and knowledge regarding cancer risks and preventive options. At t1, the extent of preparation for decision-making and acceptability of the decision aids will also be examined. Another secondary outcome variable assessed at 6-month follow-up (t2) is the extent of decision regret.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>These will be the first decision aids available for <jats:italic>BRCA1\/2<\/jats:italic> mutation carriers in Germany to be evaluated regarding their effectiveness and acceptability in clinical use within an RCT. Subsequently, they are to be integrated into the care concept of the centres of the German Consortium for Hereditary Breast and Ovarian Cancer and the affiliated breast centres.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration {2a}<\/jats:title>\n                <jats:p>DRKS <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00015823\">DRKS00015823<\/jats:ext-link>. Retrospectively registered on 14 June 2019<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06081-7","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T09:04:01Z","timestamp":1645002241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of two evidence-based decision aids for female BRCA1\/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0753-8490","authenticated-orcid":false,"given":"Sibylle","family":"Kautz-Freimuth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Reda\u00e8lli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Isselhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arim","family":"Shukri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Vodermaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Rhiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Schmutzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"23","key":"6081_CR1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402\u201316. https:\/\/doi.org\/10.1001\/jama.2017.7112.","journal-title":"JAMA."},{"issue":"4","key":"6081_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/ijc.32396","volume":"146","author":"C Engel","year":"2019","unstructured":"Engel C, Fischer C, Zachariae S, Buksch K, Rhiem K, Giesecke J, et al. on the behalf of the German Consortium for Hereditary Breast and Ovarian Cancer. Breast cancer risk in BRCA1\/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer. 2019;146(4):999\u20131009. https:\/\/doi.org\/10.1002\/ijc.32396.","journal-title":"Int J Cancer."},{"issue":"9","key":"6081_CR3","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.pec.2017.03.013","volume":"100","author":"M Dean","year":"2017","unstructured":"Dean M, Scherr CL, Clements M, Koruo R, Martinez J, Ross A. \u201cWhen information is not enough\u201d: a model for understanding BRCA-positive previvors\u2019 information needs regarding hereditary breast and ovarian cancer risk. Patient Educ Couns. 2017;100(9):1738\u201343. https:\/\/doi.org\/10.1016\/j.pec.2017.03.013.","journal-title":"Patient Educ Couns."},{"key":"6081_CR4","volume-title":"Diet, nutrition, physical activity and breast cancer survivors","author":"World Cancer Research Fund\/American Institute for Cancer Research. Continuous update project expert report","year":"2018","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Continuous update project expert report 2018. Diet, nutrition, physical activity and breast cancer survivors. http:\/\/www.wcrf.org\/sites\/default\/files\/Summary-of-Third-Expert-Report-2018.pdf. Accessed 30 Nov 2020."},{"issue":"6","key":"6081_CR5","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1186\/bcr3369","volume":"14","author":"K Rhiem","year":"2012","unstructured":"Rhiem K, Engel C, Graeser M, Zachariae S, Kast K, Kiechle M, et al. The risk of contralateral breast cancer in patients from BRCA1\/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Res. 2012;14(6):R156. https:\/\/doi.org\/10.1186\/bcr3369.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"6081_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10549-019-05152-9","volume":"175","author":"U Bick","year":"2019","unstructured":"Bick U, Engel C, Krug B, Heindel W, Fallenberg EM, Rhiem K, et al. High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat. 2019;175(1):217\u201328. https:\/\/doi.org\/10.1007\/s10549-019-05152-9.","journal-title":"Breast Cancer Res Treat."},{"issue":"5","key":"6081_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.breast.2011.04.004","volume":"20","author":"TN Spiegel","year":"2011","unstructured":"Spiegel TN, Esplen MJ, Hill KA, Wong J, Causer PA, Warner E. Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance. Breast. 2011;20(5):424\u201330. https:\/\/doi.org\/10.1016\/j.breast.2011.04.004.","journal-title":"Breast"},{"issue":"9","key":"6081_CR8","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1245\/s10434-015-4532-1","volume":"22","author":"F De Felice","year":"2015","unstructured":"De Felice F, Marchetti C, Musella A, Palaia I, Perniola G, Musio D, et al. Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis. Ann Surg Oncol. 2015;22(9):2876\u201380. https:\/\/doi.org\/10.1245\/s10434-015-4532-1.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"6081_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","volume":"177","author":"BAM Heemskerk-Gerritsen","year":"2019","unstructured":"Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AI, Collee M, Meijers-Heijboer HEJ, et al. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2019;177(3):723\u201333. https:\/\/doi.org\/10.1007\/s10549-019-05345-2.","journal-title":"Breast Cancer Res Treat."},{"issue":"15","key":"6081_CR10","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1158\/1078-0432.CCR-15-1465","volume":"22","author":"X Li","year":"2016","unstructured":"Li X, You R, Wang X, Liu C, Xu Z, Zhou J, et al. Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review. Clin Cancer Res. 2016;22(15):3971\u201381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1465.","journal-title":"Clin Cancer Res."},{"key":"6081_CR11","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF. Leitlinienprogramm Onkologie: S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Langversion 4.0 M\u00e4rz 2020; AWMF-Registernummer: 032\/035OL. [Guidelines Programme Oncology: S3-guideline diagnosis, therapy and aftercare of malignant ovarian tumours, long version 4.0 March 2020, AWMF registry number 032\/035OL] 2020. http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/ovarialkarzinom. Accessed 1 Dec 2020."},{"issue":"22","key":"6081_CR12","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2011.766","volume":"305","author":"SS Buys","year":"2011","unstructured":"Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295\u2013303. https:\/\/doi.org\/10.1001\/jama.2011.766.","journal-title":"JAMA."},{"issue":"6","key":"6081_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/jama.2017.21421","volume":"319","author":"JT Henderson","year":"2018","unstructured":"Henderson JT, Webber EM, Sawaya GF. Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;319(6):595\u2013606. https:\/\/doi.org\/10.1001\/jama.2017.21421.","journal-title":"JAMA."},{"issue":"2","key":"6081_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ygyno.2019.08.034","volume":"155","author":"J Gronwald","year":"2019","unstructured":"Gronwald J, Lubinski J, Huzarski T, Cybulski C, Menkiszak J, Siolek M, et al. A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy. Gynecol Oncol. 2019;155(2):270\u20134. https:\/\/doi.org\/10.1016\/j.ygyno.2019.08.034.","journal-title":"Gynecol Oncol."},{"issue":"2","key":"6081_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009;101(2):80\u20137. https:\/\/doi.org\/10.1093\/jnci\/djn442.","journal-title":"J Natl Cancer Inst."},{"issue":"9","key":"6081_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domcheck","year":"2010","unstructured":"Domcheck SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967\u201375. https:\/\/doi.org\/10.1001\/jama.2010.1237.","journal-title":"JAMA."},{"key":"6081_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2017.09.005","volume":"61","author":"F De Felice","year":"2017","unstructured":"De Felice F, Marchetti C, Boccia SM, Romito A, Sassu CM, Porpora MG, et al. Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: an evidence-based approach on what women should know. Cancer Treatment Rev. 2017;61:1\u20135. https:\/\/doi.org\/10.1016\/j.ctrv.2017.09.005.","journal-title":"Cancer Treatment Rev."},{"issue":"3","key":"6081_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10897-013-9667-2","volume":"23","author":"ML Underhill","year":"2014","unstructured":"Underhill ML, Crotser CB. Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation. J Genet Couns. 2014;23(3):350\u201362. https:\/\/doi.org\/10.1007\/s10897-013-9667-2.","journal-title":"J Genet Couns."},{"key":"6081_CR19","doi-asserted-by":"publisher","first-page":"W96","DOI":"10.1377\/hlthaff.w2.96","volume":"Suppl1:Web Excl","author":"JE Wennberg","year":"2002","unstructured":"Wennberg JE, Fisher ES, Skinner JS. Geography and the debate over Medicare reform. Health Aff (Millwood). 2002;Suppl1:Web Exclusives:W96\u2013114. https:\/\/doi.org\/10.1377\/hlthaff.w2.96.","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"6081_CR20","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361\u20137. https:\/\/doi.org\/10.1007\/s11606-012-2077-6.","journal-title":"J Gen Intern Med."},{"issue":"4","key":"6081_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989x03256005","volume":"23","author":"JC Brehaut","year":"2003","unstructured":"Brehaut JC, O\u2019Connor AM, Wood TJ, et al. Validation of a decision regret scale. Med Decis Making. 2003;23(4):281\u201392. https:\/\/doi.org\/10.1177\/0272989x03256005.","journal-title":"Med Decis Making."},{"issue":"4","key":"6081_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1258\/0969141042467386","volume":"11","author":"M Gattellari","year":"2004","unstructured":"Gattellari M, Ward JE. Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening. J Med Screen. 2004;11(4):165\u20139. https:\/\/doi.org\/10.1258\/0969141042467386.","journal-title":"J Med Screen."},{"key":"6081_CR23","volume-title":"Predicting downstream effects of high decisional conflict: meta-analysis of the decisional conflict scale. [Doctor of Philosophy]","author":"Q Sun","year":"2005","unstructured":"Sun Q. Predicting downstream effects of high decisional conflict: meta-analysis of the decisional conflict scale. [Doctor of Philosophy]. Ottawa: University of Ottawa; 2005. http:\/\/ruor.uottawa.ca\/bitstream\/10393\/27050\/1\/MR11422.PDF. Accessed 1. Dec 2020"},{"issue":"5","key":"6081_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1037\/a0015205","volume":"28","author":"C Rini","year":"2009","unstructured":"Rini C, O\u2019Neill SC, Valdimarsdottir H, Goldsmith RE, Jandorf L, Brown K, et al. Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1\/2 results. Health Psychol. 2009;28(5):569\u201378. https:\/\/doi.org\/10.1037\/a0015205.","journal-title":"Health Psychol."},{"issue":"4","key":"6081_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.apnr.2011.03.003","volume":"25","author":"RL Hickman","year":"2012","unstructured":"Hickman RL, Daly BJ, Lee E. Decisional conflict and regret: consequences of surrogate decision making for the chronically critically ill. Appl Nurs Res. 2012;25(4):271\u20135. https:\/\/doi.org\/10.1016\/j.apnr.2011.03.003.","journal-title":"Appl Nurs Res."},{"issue":"5","key":"6081_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","volume":"119","author":"R Manchanda","year":"2012","unstructured":"Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, et al. Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis. BJOG. 2012;119(5):527\u201336. https:\/\/doi.org\/10.1111\/j.1471-0528.2011.03257.x.","journal-title":"BJOG."},{"issue":"1","key":"6081_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1741-6787.2007.00108.x","volume":"5","author":"D Stacey","year":"2008","unstructured":"Stacey D, Murray MA, Legare F, Sandy D, Menard P, O\u2019Connor A. Decision coaching to support shared decision making: a framework, evidence, and implications for nursing practice, education, and policy. Worldviews Evid Based Nurs. 2008;5(1):25\u201335. https:\/\/doi.org\/10.1111\/j.1741-6787.2007.00108.x.","journal-title":"Worldviews Evid Based Nurs."},{"issue":"12","key":"6081_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/GIM.0b013e3181f48d1c","volume":"12","author":"C Julian-Reynier","year":"2010","unstructured":"Julian-Reynier C, Bouhnik AD, Mouret-Fourme E, Gauthier-Villars M, Berthet P, Lasset C, et al. Time to prophylactic surgery in BRCA1\/2 carriers depends on psychological and other characteristics. Genet Med. 2010;12(12):801\u20137. https:\/\/doi.org\/10.1097\/GIM.0b013e3181f48d1c.","journal-title":"Genet Med."},{"issue":"1","key":"6081_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12687-014-0201-5","volume":"6","author":"SC O\u2019Neill","year":"2015","unstructured":"O\u2019Neill SC, Mays D, Patenaude AF, Garber JE, DeMarco TA, Peshkin BN, et al. Women\u2019s concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children. J Community Genet. 2015;6(1):55\u201362. https:\/\/doi.org\/10.1007\/s12687-014-0201-5.","journal-title":"J Community Genet."},{"issue":"3","key":"6081_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1399-0004.2007.00859.x","volume":"72","author":"KA Metcalfe","year":"2007","unstructured":"Metcalfe KA, Poll A, O\u2019Connor A, Gershman S, Armel S, Finch A, et al. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clin Genet. 2007;72(3):208\u201317. https:\/\/doi.org\/10.1111\/j.1399-0004.2007.00859.x.","journal-title":"Clin Genet."},{"issue":"3","key":"6081_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/gim.2016.108","volume":"19","author":"KA Metcalfe","year":"2017","unstructured":"Metcalfe KA, Dennis CL, Poll A, Armel S, Demsky R, Carlsson L, et al. Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial. Genet Med. 2017;19(3):330\u20136. https:\/\/doi.org\/10.1038\/gim.2016.108.","journal-title":"Genet Med."},{"issue":"2","key":"6081_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/sj.bjc.6601525","volume":"90","author":"MS van Roosmalen","year":"2004","unstructured":"van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, et al. Randomised trial of a decision aid and its timing for women being tested for a BRCA1\/2 mutation. Br J Cancer. 2004;90(2):333\u201342. https:\/\/doi.org\/10.1038\/sj.bjc.6601525.","journal-title":"Br J Cancer."},{"key":"6081_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/hex.12661","volume":"21","author":"MG Harmsen","year":"2018","unstructured":"Harmsen MG, Steenbeek MP, Hoogerbrugge N, et al. A patient decision aid for risk-reducing surgery in premenopausal BRCA1\/2 mutation carriers: development process and pilot testing. Health Expect. 2018;21:659\u201367. https:\/\/doi.org\/10.1111\/hex.12661.","journal-title":"Health Expect"},{"issue":"36","key":"6081_CR34","doi-asserted-by":"publisher","first-page":"9319","DOI":"10.1200\/JCO.2005.06.119","volume":"23","author":"K Armstrong","year":"2005","unstructured":"Armstrong K, Weber B, Ubel PA, Peters N, Holmes J, Schwartz JS. Individualized survival curves improve satisfaction with cancer risk management decisions in women with BRCA1\/2 mutations. J Clin Oncol. 2005;23(36):9319\u201328. https:\/\/doi.org\/10.1200\/JCO.2005.06.119.","journal-title":"J Clin Oncol."},{"issue":"3","key":"6081_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10897-011-9350-4","volume":"20","author":"JO Culver","year":"2011","unstructured":"Culver JO, MacDonald DJ, Thornton AA, Sand SR, Grant M, Bowen DJ, et al. Development and evaluation of a decision aid for BRCA carriers with breast cancer. J Genet Couns. 2011 Jun;20(3):294\u2013307. https:\/\/doi.org\/10.1007\/s10897-011-9350-4.","journal-title":"J Genet Couns."},{"issue":"6","key":"6081_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1055\/a-1326-1792","volume":"81","author":"LM Krassuski","year":"2021","unstructured":"Krassuski LM, Kautz-Freimuth S, Vennedey V, Rhiem K, Schmutzler RK, Stock S. Decision aids for preventive treatment alternatives for BRCA1\/2 mutation carriers: a systematic review. Geburtshilfe Frauenheilk. 2021;81(6):679\u201398. https:\/\/doi.org\/10.1055\/a-1326-1792.","journal-title":"Geburtshilfe Frauenheilk."},{"issue":"1","key":"6081_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12911-019-0872-2","volume":"19","author":"L Krassuski","year":"2019","unstructured":"Krassuski L, Vennedey V, Stock S, Kautz-Freimuth S. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review. BMC Med Inform Decis Mak. 2019;19(1):154. https:\/\/doi.org\/10.1186\/s12911-019-0872-2.","journal-title":"BMC Med Inform Decis Mak."},{"issue":"4","key":"6081_CR38","doi-asserted-by":"publisher","first-page":"CD001431","DOI":"10.1002\/14651858.CD001431.pub5","volume":"4","author":"D Stacey","year":"2017","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4(4):CD001431. https:\/\/doi.org\/10.1002\/14651858.CD001431.pub5.","journal-title":"Cochrane Database Syst Rev"},{"key":"6081_CR39","unstructured":"Deutsches Konsortium Famili\u00e4rer Brust- und Eierstockkrebs [German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC)]. http:\/\/www.konsortium-familiaerer-brustkrebs.de\/ (2020). Accessed 1 Dec 2020."},{"key":"6081_CR40","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF. Leitlinienprogramm Onkologie: Interdisziplin\u00e4re S3-Leitlinie f\u00fcr die Fr\u00fcherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms, Langversion 4.3, AWMF-Registernummer: 32-045OL. 2020. [Guidelines programme oncology: interdisciplinary S3-guideline for screening, diagnosis, therapy and aftercare of breast carcinoma, long version 4.3, AWMF registry number: 32-045OL]. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Mammakarzinom_4_0\/Version_4.3\/LL_Mammakarzinom_Langversion_4.3.pdf. Accessed 1 Dec 2020."},{"key":"6081_CR41","first-page":"2020","volume":"1","author":"AGO Breast Committee","year":"2020","unstructured":"AGO Breast Committee. Diagnosis and treatment of patients with early and advanced breast cancer. Guidelines breast version. 2020;1:2020 http:\/\/www.ago-online.de\/fileadmin\/ago-online\/downloads\/_leitlinien\/kommission_mamma\/2020\/Updated_Guidelines_2020.pdf. Accessed 1 Dec 2020.","journal-title":"Guidelines breast version"},{"key":"6081_CR42","unstructured":"O\u2019Connor AM, Jacobsen MJ. Workbook on developing and evaluating patient decision aids. Ottawa. 2003; http:\/\/decisionaid.ohri.ca\/docs\/develop\/Develop_DA.pdf. Accessed 1 Dec 2020."},{"issue":"3","key":"6081_CR43","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1377\/hlthaff.26.3.716","volume":"26","author":"AM O\u2019Connor","year":"2007","unstructured":"O\u2019Connor AM, Wennberg JE, Legare F, Llewellyn-Thomas HA, Moulton BW, Sepucha KR, et al. Toward the \u2018tipping point\u2019: decision aids and informed patient choice. Health Aff. 2007;26(3):716\u201325. https:\/\/doi.org\/10.1377\/hlthaff.26.3.716.","journal-title":"Health Aff."},{"issue":"1","key":"6081_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12911-021-01528-4","volume":"21","author":"S Kautz-Freimuth","year":"2021","unstructured":"Kautz-Freimuth S, Reda\u00e8lli M, Rhiem K, Vodermaier A, Krassuski L, Nicolai K, et al. Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making. BMC Med Inform Dec Mak. 2021;21(1):180. https:\/\/doi.org\/10.1186\/s12911-021-01528-4.","journal-title":"BMC Med Inform Dec Mak."},{"key":"6081_CR45","volume-title":"IPDAS 2005: criteria for judging the quality of patient decision aids","author":"International Patient Decision Aid Standards (IPDAS) Collaboration","year":"2005","unstructured":"International Patient Decision Aid Standards (IPDAS) Collaboration. IPDAS 2005: criteria for judging the quality of patient decision aids 2005. http:\/\/ipdas.ohri.ca\/IPDAS_checklist.pdf. Accessed 30 November 2020."},{"issue":"7565","key":"6081_CR46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bmj.38926.629329.AE","volume":"333","author":"G Elwyn","year":"2006","unstructured":"Elwyn G, O\u2019Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417\u20139. https:\/\/doi.org\/10.1136\/bmj.38926.629329.AE.","journal-title":"BMJ"},{"issue":"Suppl 2","key":"6081_CR47","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1472-6947-13-S2-S2","volume":"13","author":"A Coulter","year":"2013","unstructured":"Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S2. https:\/\/doi.org\/10.1186\/1472-6947-13-S2-S2.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"6","key":"6081_CR48","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1177\/0272989X13501721","volume":"34","author":"N Joseph-Williams","year":"2014","unstructured":"Joseph-Williams N, Newcombe R, Politi M, Durand MA, Sivell S, Stacey D, et al. Toward minimum standards for certifying patient decision aids: a modified Delphi consensus process. Med Decis Making. 2014;34(6):699\u2013710. https:\/\/doi.org\/10.1177\/0272989X13501721.","journal-title":"Med Decis Making."},{"issue":"3","key":"6081_CR49","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotscher PC, Krlezua-Jeric K, et al. SPIRIT 2013 statements: defining stand protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med."},{"issue":"3","key":"6081_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/tbj.13257","volume":"25","author":"K Rhiem","year":"2019","unstructured":"Rhiem K, Bucker-Nott HJ, Hellmich M, Fischer H, Ataseven B, Dittmer-Grabowski C, et al. Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort. Breast J. 2019;25(3):455\u201360. https:\/\/doi.org\/10.1111\/tbj.13257.","journal-title":"Breast J."},{"key":"6081_CR51","unstructured":"O\u2019Connor AM. User manual - decisional conflict scale. 1993, 2010. Ottawa Hospital Research Institute, Ottawa, Canada. \/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_Decisional_Conflict.pdf. Accessed 1 Dec 2020."},{"key":"6081_CR52","unstructured":"O\u2019Connor AM. User manual - stage of decision making. 2000, 2003. Ottawa Hospital Research Institute, Ottawa, Canada. \/\/decisionaid.ohri.ca\/docs\/develop\/user_manuals\/um_stage_decision_making.pdf. Accessed 1 Dec 2020."},{"issue":"6","key":"6081_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica. 1983;67(6):361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"6081_CR54","volume-title":"Deutsche Adaptation der Hospital Anxiety and Depression Scale (HADS) von R.P. Snaith und A.S. Zigmond","author":"C Herrmann-Lingen","year":"2011","unstructured":"Herrmann-Lingen C, Buss U, Snaith R. HADS-D. Hospital Anxiety and Depression Scale - Deutsche Version. In: Deutsche Adaptation der Hospital Anxiety and Depression Scale (HADS) von R.P. Snaith und A.S. Zigmond. 3rd ed. Bern: Huber; 2011.","edition":"3"},{"key":"6081_CR55","first-page":"399","volume-title":"Assessing psychological trauma and PTSD","author":"DS Weiss","year":"1996","unstructured":"Weiss DS, Marmar CR. The Impact of Event Scale - Revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. New York: Guilford; 1996. p. 399\u2013411."},{"key":"6081_CR56","unstructured":"Graham ID, O\u2019Connor AM. User manual - preparation for decision making scale. 1995, 2010. Ottawa Hospital Research Institute, Ottawa, Canada. \/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_PrepDM.pdf. Accessed 1 Dec 2020."},{"key":"6081_CR57","unstructured":"Graham ID, O\u2019Connor AM. Preparation for decision making scale. 1995, 2005, German Translation 2006. University of Ottawa. \/\/decisionaid.ohri.ca\/docs\/develop\/Tools\/PrepDM_German.pdf. Accessed 1 Dec 2020."},{"key":"6081_CR58","unstructured":"O\u2019Connor AM, Cranney A. User manual - acceptability. 1996, 2002. Ottawa Hospital Research Institute, Ottawa, Canada. \/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_Acceptability.pdf. Accessed 1 Dec 2020."},{"key":"6081_CR59","unstructured":"O\u2019Connor AM. User manual - decision regret scale. 1996, 2003. Ottawa Hospital Research Institute, Ottawa, Canada. \/\/decisionaid.ohri.ca\/docs\/develop\/Unser_Manuals\/UM_Regret_Scale.pdf. Accessed 1 Dec 2020."},{"key":"6081_CR60","first-page":"15","volume":"4","author":"A Buchholz","year":"2011","unstructured":"Buchholz A, H\u00f6lzel L, Kriston L, Simon D, H\u00e4rter M. Die Decisional Conflict Scale in deutscher Sprache (DCS-D) - Dimensionale Struktur in einer Stichprobe von Hausarztpatienten. [The Decisional Conflict Scale in German (DCS-D) - dimensional structure in a sample of general practitioner patients]. Klin Diagnostik u Evaluation. 2011;4:15\u201330.","journal-title":"Klin Diagnostik u Evaluation"},{"key":"6081_CR61","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWIG): Entscheidungshilfe. 2013, 2016. [German translation and adaption of the Stage of Decision Making Scale]. http:\/\/www.gesundheitsinformation.de\/zum-ausfullen-eine-entscheidungshilfe.2221.de.html. Accessed 1 Dec 2020."},{"issue":"21","key":"6081_CR62","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/jnci\/djp336","volume":"101","author":"A Vodermaier","year":"2009","unstructured":"Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101(21):1464\u201388. https:\/\/doi.org\/10.1093\/jnci\/djp336.","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"6081_CR63","first-page":"130","volume":"44","author":"A Maercker","year":"1998","unstructured":"Maercker A, Sch\u00fctzwohl M. Erfassung von psychischen Belastungsfolgen: Die Impact of Event Skala-revidierte Version (IES-R). [Assessment of post-traumatic stress reactions: The Impact of Event Scale-Revised (IES-R)]. Diagnostica. 1998;44(3):130\u201341.","journal-title":"Diagnostica"},{"issue":"1","key":"6081_CR64","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.pec.2009.05.012","volume":"78","author":"C Bennet","year":"2010","unstructured":"Bennet C, Graham ID, Kristjannson E, Kearing SA, Clay KF, O\u2019Connor AM. Validation of a preparation for decision making scale. Patient Educ Couns. 2010;78(1):130\u20133. https:\/\/doi.org\/10.1016\/j.pec.2009.05.012.","journal-title":"Patient Educ Couns."},{"key":"6081_CR65","first-page":"31","volume":"4","author":"A Buchholz","year":"2011","unstructured":"Buchholz A, Simon D, H\u00e4rter M. Die Preparation for Decision Making Scale in deutscher Sprache (PDMS-D) - Faktorielle und konkurrente Validit\u00e4t in einer Onlinestichprobe von Personen mit Kreuzschmerz oder Depression. [The Preparation for Decision Making Scale in German language (PDMS-D) - factorial and concurrent validity in an online sample of people with low back pain or depression]. Klin Diagnostik u Evaluation. 2011;4:31\u201345.","journal-title":"Klin Diagnostik u Evaluation."},{"issue":"40","key":"6081_CR66","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3238\/arztebl.2015.0672","volume":"112","author":"A Buchholz","year":"2015","unstructured":"Buchholz A, H\u00e4rter M. Projekt PPO \u2013 Patient als Partner in der Onkologie. Universit\u00e4tsklinikum Hamburg-Eppendorf. Used in: H\u00e4rter M, Buchholz A, Nicolai J, Reuter K, Komarahadi F, Kriston L, Kallinowski B, Eich W, Bieber C. Shared decision making and the use of decision aids - a cluster-randomized study on the efficacy of a training in an oncology setting. Dtsch Arztebl Int. 2015;112(40):672\u20139. https:\/\/doi.org\/10.3238\/arztebl.2015.0672.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"6081_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0272989X0102100101","volume":"21","author":"V Goel","year":"2001","unstructured":"Goel V, Sawkan CA, Thiel EC, Gort EH, O\u2019Connor A. Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. Med Decis Making. 2001;21(1):1\u20136. https:\/\/doi.org\/10.1177\/0272989X0102100101.","journal-title":"Med Decis Making."},{"issue":"6","key":"6081_CR68","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/bjc.2012.61","volume":"106","author":"M Peate","year":"2012","unstructured":"Peate M, Meiser B, Cheah BC, Saunders C, Butow P, Thewes B, et al. Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. British J Cancer. 2012;106(6):1053\u201361. https:\/\/doi.org\/10.1038\/bjc.2012.61.","journal-title":"British J Cancer"},{"issue":"1","key":"6081_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1037\/a0013147","volume":"28","author":"MD Schwartz","year":"2009","unstructured":"Schwartz MD, Valdimarsdottir HB, DeMarco TA, Peshkin BN, Lawrence W, Rispoli J, et al. Randomized trial of a decision aid for BRCA1\/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychol. 2009;28(1):11\u20139. https:\/\/doi.org\/10.1037\/a0013147.","journal-title":"Health Psychol."},{"issue":"3","key":"6081_CR70","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0272989X10381283","volume":"31","author":"GW Hooker","year":"2011","unstructured":"Hooker GW, Leventhal KG, DeMarco T, Peshkin BN, Finch C, Wahl E, et al. Longitudinal changes in patient distress following interactive decision aid use among BRCA1\/2 carriers: a randomized trial. Med Decis Making. 2011;31(3):412\u201321. https:\/\/doi.org\/10.1177\/0272989X10381283.","journal-title":"Med Decis Making."},{"key":"6081_CR71","volume-title":"A language and environment for statistical computing","author":"R Core Team. R","year":"2020","unstructured":"R Core Team. R. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. http:\/\/www.R-project.org\/. Accessed 1 Dec 2020"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06081-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T07:06:44Z","timestamp":1652771204000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06081-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6081"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06081-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"26 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Funding section has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before starting this trial, this project was approved by the Ethics Committee of the Faculty of Medicine of the University of Cologne [ethical approval given 26 April 2017, reference number 17-128].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"157"}}